This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Many stroke patients not screened for ...   The majority of stroke survivors are not screened or ... (22 Apr 2019)
Skipping Breakfast Associated with Increased ... Eating breakfast regularly lowered cardiovascular-specific and ... (22 Apr 2019)
Physical Activity May Offset Mortality Risk ... For less active adults, the amount of time spent sitting may be ... (22 Apr 2019)
PCI after heart attack may be lifesaver for ...   Among heart attack patients 75 years and older, the oldest ... (22 Apr 2019)
Plant-based Diets Can be Effective in ... New study looks at how five diet patterns may impact risk of ... (22 Apr 2019)
Friday, 13 July 2018 22:12

Valsartan: Updated list of potentially impacted products Featured

Rate this item
(0 votes)

The Superintendent of Public Health has issued an updated list of products with the active substance valsartan that may be potentially impacted by the N-nitrosodimethylamine (NDMA) impurity.

 

 

 

It is important to note that treatment should not be stopped until the patient has been prescribed an alternative. The health risk of discontinuing this medicine is higher than any potential risk presented by the impurity. At present there is no evidence that the impurity in some stocks of valsartan has caused any harm to patients. Further updates will be provided as more information becomes available.

 

Read 506 times

Latest news

Highlights

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…